Dr. Saad Usmani
Levine Cancer Institute
Carolinas Healthcare System
Charlotte, NC

With support from Amgen, Bristol Myers Squibb, Celgene, Janssen Pharmaceuticals, and Takeda Oncology.


Dr. Saad Usmani is Chief of Plasma Cell Disorders and Director of Clinical Research in Hematologic Malignancies at the Levine Cancer Institute Hematologic Oncology and Blood Disorders and Carolinas HealthCare System.

Previous Post
ASH 2015: Oral Doxycycline Improves Outcomes of Stage III Amyloidosis - a Matched Case Control Study
Next Post
ASH 2015: Dr. Sagar Lonial ASH Overview

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.